Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: A case series of 18 patients
Choi CJ, Nghiem P. Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients. Arch Dermatol 2001; 137: 1202-1206.
Treatment of extensive chronic cutaneous graft-versus-host disease in an infant with topical pimecrolimus
Ziemer M, Gruhn B, Thiele JJ, Elsner P. Treatment of extensive chronic cutaneous graft-versus-host disease in an infant with topical pimecrolimus. J Am Acad Dermatol 2004; 50: 946-948.
Topical tacrolimus - A novel treatment alternative for cutaneous chronic graft-versus-host disease
Elad S, Or R, Resnick I, Shapira MY. Topical tacrolimus - a novel treatment alternative for cutaneous chronic graft-versus-host disease. Transpl Int 2003; 16: 665-670.
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors
Nash RA, Antin JH, Karanes C, Fay JW, Avalos BR, Yeager AM, et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 2000; 96: 2062-2068.
Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: Highly effective treatment with topical tacrolimus
in press
Eckard A, Starke O, Stadler M, Reuter C, Hertenstein B. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus. Oral Oncology 2004 (in press).